Login

Financial Snapshot

Revenue
TTM
$725.0K
Gross Margin
TTM
-7.15%
Net Income
TTM
$850.0K
Current Assets
2023 Q1
Current Liabilities
2023 Q1
Current Ratio
2023 Q1
59.0%
Total Assets
2023 Q1
Total Liabilities
2023 Q1
Book Value
2023 Q1
-$458.0K
Cash
2023 Q1
P/E
TTM
0.005659
Free Cash Flow
Last 4 Quarters
N/A

Stock Price

Loading...
Market Cap: $4.81 Thousand

About AMERICAN BIO MEDICA CORP

American Bio Medica Corp. is a biotechnology company, which engages in the manufacture and sale of immunoassay tests, primarily for the immediate detection of certain drugs in urine and oral fluids. The company is headquartered in Kinderhook, New York. The firm also distributes a number of other products related to the immediate detection of drugs and alcohol. The company manufactures a number of products that detect the presence or absence of drugs in urine. The company manufactures the various urine drug testing product lines, including The Rapid Drug Screen (RDS), RDS InCup, Rapid TOX, Rapid TOX Cup and Private Label Products. RDS is a patented rapid drug test that detects the presence or absence of 2-10 drugs simultaneously in a single urine specimen. RDS InCup is a drug-testing cup that detects the presence or absence of 1-12 drugs in a urine specimen. Its OralStat is a drug test for the detection of drugs in oral fluids. Its Respiratory Syncytial Virus (RSV) test does detect RSV in both children under the age of six, as well as adults over the age of 60.

Industry: Pharmaceutical Preparations Peers: Abbott Laboratories QUANTRX BIOMEDICAL CORP THC Therapeutics, Inc. Bionik Laboratories Corp. ECGI Holdings, Inc. Escalon Medical Corp Zosano Pharma Corp

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support